In-vitro fertilization is a type of assisted
reproductive technology that helps women in conceiving. The global IVF market
was valued at $9.3 billion in 2012 and is expected to grow up to $21.6 billion
by 2020. Delayed pregnancy in women is one of the major driving factors of the
IVF market, as the chances of conceiving lowers with age. The pregnancy success
rate with IVF technique is higher in the age group of 35-39. Other
driving factors of the IVF market are rise in infertility rate due to rise in
stress levels, change in life style and fertility related diseases. Globally,
the number of couples with infertility issues was found to be 48.5 million in
2010.The major limiting factor of this market is the cost involved in the
treatment. The patient may not conceive in the first cycle of IVF procedure.
Get detailed report at: http://www.reportsandintelligence.com/in-vitro-fertilization-market
Many cycles have to be undergone by the patient to
achieve pregnancy, and this adds to the overall cost. The average cost of this
procedure is approximately $10,000-$20,000. This acts as a major limitation in
adoption of the technique for people with low income. Another challenge is the
low level of awareness in the developing economies such as Nigeria. Awareness
can be created through medical tourism and availability of low cost IVF
treatments.
The companies profiled in this report include Vitrolife
AB, Cooper Surgical. Inc., Cook Medicals, Thermo Scientific, Irvine Scientific
Inc., Genea Biomedx, Oxford Gene Technology, Auxogyn Inc., EMD Serono Inc. and
Ova Science.
No comments:
Post a Comment